Nov 9, 2023 · Allogeneic SCT carries the potential benefit of a graft-versus-myeloma effect resulting in a lower risk of relapse in comparison to that following autologous ...

Jun 3, 2024 · Tandem autologous/reduced-intensity conditioning allogeneic stem-cell transplantation versus autologous transplantation in myeloma: Long-term follow-up.

Apr 25, 2024 · MM patients who received autologous tandem allogeneic HSCT did not achieve better response compared to tandem autologous HSCT. In summary, compared to single ...

Feb 21, 2024 · Autologous Stem Cell Transplant for Multiple Myeloma: Impact of Eliminating Day of Rest on Incidence of Complications and Re-Admission Rate · Developing Practice ...

Sep 3, 2024 · The use of autologous stem cell transplantation (ASCT) in multiple myeloma (MM) is the standard of care in patients who are deemed transplantation eligible.

Dec 18, 2023 · This review provides a comprehensive picture of the effectiveness and the safety of ASCT as a therapeutic approach for these diseases, based on the currently ...

Feb 21, 2024 · Long-Term Outcomes of Autologous Stem Cell Transplant ... and High-Dose Melphalan Reduced Intensity Conditioning Regimen for Allogeneic Stem Cell Transplantation.

Sep 16, 2024 · These data suggest that planned tandem autologous allograft can improve overall survival compared with upfront RIC allograft alone in patients with multiple ...

Oct 1, 2024 · A planned tandem non-myeloablative allogeneic transplantation following an autologous transplantation is considered medically necessary for treatment of ...